NOT-HL-23-085: NHLBI Notice of Availability of Frequently Asked Questions (FAQs) for NOT-HL-23-078 and NOT-HL-23-079 (CAROL Act)

NHLBI Notice of Availability of Frequently Asked Questions (FAQs) for NOT-HL-23-078 and NOT-HL-23-079 (CAROL Act)

Notice Number:

NOT-HL-23-085

Key Dates

Release Date:

April 4, 2023

Related Announcements

NOT-HL-23-078 - Notice of Special Interest (NOSI): Administrative Supplements to Encourage Research in Valvular Heart Disease (CAROL Act)

NOT-HL-23-079 - Notice of Special Interest (NOSI): Research Project Grants in Valvular Heart Disease (CAROL Act)

PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

PA-21-071 - Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

This Notice informs potential applicants that the NHLBI has posted responses to Frequently Asked Questions (FAQs) regarding the CAROL Act NOSIs at:

In addition, the NHLBI informs potential applicants that the Institute may also consider grant applications that use other mechanisms, such as the clinical trial mechanisms summarized at NHLBI Clinical Trial Development Continuum, for funding under the CAROL Act.

Inquiries

Please direct all inquiries regarding this Notice to:

Frank Evans, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-402-2647
Email: frank.evans@nih.gov